|
#1
|
|||
|
|||
Re: Favorite risky plays
[ QUOTE ]
XOMA is not a takeover target for PFE, or likely anybody. I've followed the name for 15+ years. They could have bot all they wanted at $1 last year. It's gone from $30 to 1 to 16 to 1 to 4 etc. They haven't gotten any real products they wanted approved, ever. [/ QUOTE ] I sure haven't looked at the stock much but I thought Lucentis was a pretty profitable product for them. Who do you think is a good takeover target in the Pharms then? PDLI? Hope you say yes here, I picked up a few hundred shares around $17.50 during Thanksgiving week just in case they were. Jimbo |
|
|